Drug Type Biosimilar, Hormone |
Synonyms 30/70 Mixture Recombinant Human Insulin, Isophane Protamine Recombinant Human Insulin, Isophane Protamine Recombinant Human Insulin Mixture(40/60) + [4] |
Target |
Action agonists |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 1998), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus | China | 01 Jan 1998 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | NDA/BLA | European Union | 01 Feb 2023 |